Trial Profile
A 12-Week, Double-Blind, Placebo-Controlled, Trial of Duloxetine Versus Placebo in the Treatment of Binge Eating Disorder and Comorbid Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2012
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Binge-eating disorder; Depressive disorders
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2012 Results published in the International Journal of Eating Disorders.
- 14 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2008 New trial record.